Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn Morris

Showing results (241-250 of 324) with videos related to

Pageof 33
Sort By:
Scientific Reports|February 14, 2025
Population shift in antibody immunity following the emergence of a SARS-CoV-2 variant of concernJinal N Bhiman, Vimbai Sharon Madzorera, Qiniso Mkhize, et al.
Nature Medicine|October 13, 2015
Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodiesJinal N Bhiman, Colin Anthony, Nicole A Doria-Rose, et al.
Nature Medicine|March 3, 2021
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasmaConstantinos Kurt Wibmer, Frances Ayres, Tandile Hermanus, et al.
Human Vaccines & Immunotherapeutics|July 2, 2021
Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participantsYunda Huang, Lily Zhang, Amanda Eaton, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 8, 2020
The V2 loop of HIV gp120 delivers costimulatory signals to CD4<sup>+</sup> T cells through Integrin α<sub>4</sub>β<sub>7</sub> and promotes cellular activation and infectionLivia R Goes, Alia Sajani, Aida Sivro, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasmaConstantinos Kurt Wibmer, Frances Ayres, Tandile Hermanus, et al.
AIDS Research and Human Retroviruses|June 10, 2005
Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern AfricaClive M Gray, Carolyn Williamson, Helba Bredell, et al.
Plos One|February 21, 2009
International network for comparison of HIV neutralization assays: the NeutNet reportEva Maria Fenyö, Alan Heath, Stefania Dispinseri, et al.
Plos One|October 8, 2011
Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sortingLynn Morris, Xi Chen, Munir Alam, et al.
Molecular Therapy. Methods & Clinical Development|July 24, 2019
AAV-Mediated Expression of Broadly Neutralizing and Vaccine-like Antibodies Targeting the HIV-1 Envelope V2 RegionFiona T van den Berg, Nigel A Makoah, Stuart A Ali, et al.
Pageof 33

Showing results (241-250 of 324) with videos related to

Sort By:
Pageof 33
Scientific Reports|February 14, 2025
Population shift in antibody immunity following the emergence of a SARS-CoV-2 variant of concernJinal N Bhiman, Vimbai Sharon Madzorera, Qiniso Mkhize, et al.
Nature Medicine|October 13, 2015
Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodiesJinal N Bhiman, Colin Anthony, Nicole A Doria-Rose, et al.
Nature Medicine|March 3, 2021
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasmaConstantinos Kurt Wibmer, Frances Ayres, Tandile Hermanus, et al.
Human Vaccines & Immunotherapeutics|July 2, 2021
Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participantsYunda Huang, Lily Zhang, Amanda Eaton, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 8, 2020
The V2 loop of HIV gp120 delivers costimulatory signals to CD4<sup>+</sup> T cells through Integrin α<sub>4</sub>β<sub>7</sub> and promotes cellular activation and infectionLivia R Goes, Alia Sajani, Aida Sivro, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasmaConstantinos Kurt Wibmer, Frances Ayres, Tandile Hermanus, et al.
AIDS Research and Human Retroviruses|June 10, 2005
Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern AfricaClive M Gray, Carolyn Williamson, Helba Bredell, et al.
Plos One|February 21, 2009
International network for comparison of HIV neutralization assays: the NeutNet reportEva Maria Fenyö, Alan Heath, Stefania Dispinseri, et al.
Plos One|October 8, 2011
Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sortingLynn Morris, Xi Chen, Munir Alam, et al.
Molecular Therapy. Methods & Clinical Development|July 24, 2019
AAV-Mediated Expression of Broadly Neutralizing and Vaccine-like Antibodies Targeting the HIV-1 Envelope V2 RegionFiona T van den Berg, Nigel A Makoah, Stuart A Ali, et al.
Pageof 33